Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T23:12:25.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T16:49:41.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T11:58:27.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T04:14:18.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T23:34:56.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-15T01:32:13.000Z thumbnail image

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.